Ngan Huang to Receive the Inaugural 2024 Elena Aikawa Trailblazer Award

by Mary Sheridan Bilbao, PA-C, MPAS
July 19, 2024

Ngan Huang, PhD, Associate Professor in the Stanford Cardiothoracic Surgery Department, has been awarded the 2024 Elena Aikawa Trailblazer Award by the International Society for Applied Cardiovascular Biology (ISACB).  

The ISACB is dedicated to enhancing discovery, development and clinical translation of cutting edge biomedical science for innovative, state of the art cardiovascular diagnostic and therapeutic modalities.  This prestigious award is named after Dr. Elena Aikawa in recognition of her scientific accomplishments and dedication to mentoring female and underrepresented scientists. 

Read the announcement from the ISACB and join us in congratulating Dr. Ngan Huang on her esteemed award and recognition.

Read more about this prestigious award here.

The ISACB Women’s Leadership Committee is pleased to name Ngan Huang, PhD as the 2024 recipient of the Elena Aikawa Trailblazer Award. The Trailblazer award recognizes a female member of ISACB who is at mid-career stage and has made substantial contributions to the applied cardiovascular research field and to the ISACB community

Ngan F. Huang is an Associate Professor in the Department of Cardiothoracic Surgery at Stanford University and Research Career Scientist at the Veterans Affairs Palo Alto Health Care System.  Dr. Huang completed her BS in Chemical Engineering from the Massachusetts Institute of Technology, followed by a PhD in bioengineering from the University of California Berkeley & University of California San Francisco Joint Program in Bioengineering.  Prior to joining the faculty, she was a postdoctoral scholar in the Division of Cardiovascular Medicine at Stanford University.  Her laboratory investigates the interactions between stem cells and extracellular matrix microenvironment for engineering cardiovascular tissues to treat cardiovascular and musculoskeletal diseases. Recent research focuses on the role of microgravity for drug screening of engineered muscle tissue.  Dr. Huang has authored over 90 publications and patents, including those in Nat Med, PNAS, and Circ Res.  She has received numerous honors, most recently including the Society for Biomaterials Mid-Career Award and the Alan Hirsch Mid-Career Award in Vascular Medicine from the American Heart Association. She has been inducted as a fellow of the American Heart Association as well as the American Institute for Medical and Biological Engineering.  She has active or completed projects funded by the NIH, NSF, AHA, Department of Defense, California Institute of Regenerative Medicine, and Department of Veteran Affairs.

Dr. Huang will be giving a lecture at the 2024 IVBM meeting in Vienna in a session dedicated to this award.

Dr. Ngan Huang